Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States
- PMID: 23551121
- PMCID: PMC3708105
- DOI: 10.1111/nyas.12098
Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States
Abstract
There is an epidemic of diabetes in Asia. Type 2 diabetes develops in East Asian patients at a lower mean body mass index (BMI) compared with those of European descent. At any given BMI, East Asians have a greater amount of body fat and a tendency to visceral adiposity. In Asian patients, diabetes develops at a younger age and is characterized by early β cell dysfunction in the setting of insulin resistance, with many requiring early insulin treatment. The increasing proportion of young-onset and childhood type 2 diabetes is posing a particular threat, with these patients being at increased risk of developing diabetic complications. East Asian patients with type 2 diabetes have a higher risk of developing renal complications than Europeans and, with regard to cardiovascular complications, a predisposition for developing strokes. In addition to cardiovascular-renal disease, cancer is emerging as the other main cause of mortality. While more research is needed to explain these interethnic differences, urgent and concerted actions are needed to raise awareness, facilitate early diagnosis, and encourage preventive strategies to combat these growing disease burdens.
© 2013 New York Academy of Sciences.
Figures
![Figure 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbd/3708105/3c8f838f08e5/nyas1281-0064-f1.gif)
![Figure 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbd/3708105/c8f8a4214f6e/nyas1281-0064-f2.gif)
![Figure 3](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbd/3708105/88e5667e537d/nyas1281-0064-f3.gif)
![Figure 4](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbd/3708105/2831bd30474f/nyas1281-0064-f4.gif)
![Figure 5](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbd/3708105/0e0cefb97ee3/nyas1281-0064-f5.gif)
Similar articles
-
Type 2 diabetes in South Asians: similarities and differences with white Caucasian and other populations.Ann N Y Acad Sci. 2013 Apr;1281(1):51-63. doi: 10.1111/j.1749-6632.2012.06838.x. Epub 2013 Jan 14. Ann N Y Acad Sci. 2013. PMID: 23317344 Free PMC article. Review.
-
Obesity-related non-communicable diseases: South Asians vs White Caucasians.Int J Obes (Lond). 2011 Feb;35(2):167-87. doi: 10.1038/ijo.2010.135. Epub 2010 Jul 20. Int J Obes (Lond). 2011. PMID: 20644557 Review.
-
Attenuation of microvascular function in those with cardiovascular disease is similar in patients of Indian Asian and European descent.BMC Cardiovasc Disord. 2010 Jan 15;10:3. doi: 10.1186/1471-2261-10-3. BMC Cardiovasc Disord. 2010. PMID: 20078879 Free PMC article.
-
Association between the APOA2 promoter polymorphism and body weight in Mediterranean and Asian populations: replication of a gene-saturated fat interaction.Int J Obes (Lond). 2011 May;35(5):666-75. doi: 10.1038/ijo.2010.187. Epub 2010 Oct 26. Int J Obes (Lond). 2011. PMID: 20975728 Free PMC article.
-
The relationship between metabolic risk factors and incident cardiovascular disease in Europeans, South Asians, and African Caribbeans: SABRE (Southall and Brent Revisited) -- a prospective population-based study.J Am Coll Cardiol. 2013 Apr 30;61(17):1777-86. doi: 10.1016/j.jacc.2012.12.046. Epub 2013 Feb 28. J Am Coll Cardiol. 2013. PMID: 23500273 Free PMC article.
Cited by
-
The different hypoglycemic effects between East Asian and non-Asian type 2 diabetes patients when treated with SGLT-2 inhibitors as an add-on treatment for metformin: a systematic review and meta-analysis of randomized controlled trials.Aging (Albany NY). 2021 May 11;13(9):12748-12765. doi: 10.18632/aging.202945. Epub 2021 May 11. Aging (Albany NY). 2021. PMID: 33973870 Free PMC article.
-
Tryptophan Predicts the Risk for Future Type 2 Diabetes.PLoS One. 2016 Sep 6;11(9):e0162192. doi: 10.1371/journal.pone.0162192. eCollection 2016. PLoS One. 2016. PMID: 27598004 Free PMC article.
-
Drug-subphenotype interactions for cancer in type 2 diabetes mellitus.Nat Rev Endocrinol. 2015 Jun;11(6):372-9. doi: 10.1038/nrendo.2015.37. Epub 2015 Mar 24. Nat Rev Endocrinol. 2015. PMID: 25801918 Review.
-
The Role of Lifestyle Intervention, in Addition to Drugs, for Diabetic Kidney Disease with Sarcopenic Obesity.Life (Basel). 2022 Mar 6;12(3):380. doi: 10.3390/life12030380. Life (Basel). 2022. PMID: 35330131 Free PMC article. Review.
-
The Effect of Blood Lipids, Type 2 Diabetes, and Body Mass Index on Parkinson's Disease: A Korean Mendelian Randomization Study.J Mov Disord. 2023 Jan;16(1):79-85. doi: 10.14802/jmd.22175. Epub 2023 Jan 12. J Mov Disord. 2023. PMID: 36628424 Free PMC article.
References
-
- International Diabetes Federation. Diabetes Atlas. 5th ed. Belgium: IDF; 2011. - PubMed
-
- Yoon KH, Lee JH, Kim JW, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006;368:1681–1688. - PubMed
-
- Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301:2129–2140. - PubMed
-
- Ramachandran A, Ma RC, Snehalatha C. Diabetes in Asia. Lancet. 2010;375:408–418. - PubMed
-
- Ma RC, Tong PC. “Epidemiology of type 2 diabetes”. In: Holt R, Goldstein B, Flyvbjerg A, Cockram CS, editors. Textbook of Diabetes. 4th ed. New York: Wiley-Blackwell; 2010. pp. 45–68.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical